NO20013001D0 - 2,3,4,4A-tetrahydro-1H-pyrazino (1,2-A) quinoxaline-5 (6H) one derivatives which are 5HT2C agonists - Google Patents
2,3,4,4A-tetrahydro-1H-pyrazino (1,2-A) quinoxaline-5 (6H) one derivatives which are 5HT2C agonistsInfo
- Publication number
- NO20013001D0 NO20013001D0 NO20013001A NO20013001A NO20013001D0 NO 20013001 D0 NO20013001 D0 NO 20013001D0 NO 20013001 A NO20013001 A NO 20013001A NO 20013001 A NO20013001 A NO 20013001A NO 20013001 D0 NO20013001 D0 NO 20013001D0
- Authority
- NO
- Norway
- Prior art keywords
- pyrazino
- quinoxaline
- tetrahydro
- derivatives
- 5ht2c agonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Anesthesiology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21347198A | 1998-12-17 | 1998-12-17 | |
PCT/US1999/029894 WO2000035922A1 (en) | 1998-12-17 | 1999-12-16 | 2,3,4,4a-tetrahydro-1h-pyrazino(1,2-a)quinoxalin-5(6h)one derivates being 5ht2c agonists |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20013001D0 true NO20013001D0 (en) | 2001-06-15 |
NO20013001L NO20013001L (en) | 2001-06-15 |
Family
ID=22795247
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20013001A NO20013001L (en) | 1998-12-17 | 2001-06-15 | 2,3,4,4A-tetrahydro-1H-pyrazino (1,2-A) quinoxaline-5 (6H) one derivatives which are 5HT2C agonists |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1140940A1 (en) |
JP (1) | JP2002532504A (en) |
KR (1) | KR20010108025A (en) |
CN (1) | CN1240701C (en) |
AR (1) | AR022687A1 (en) |
AU (1) | AU3123400A (en) |
BR (1) | BR9916326A (en) |
CA (1) | CA2351385A1 (en) |
CZ (1) | CZ20012193A3 (en) |
EA (1) | EA200100671A1 (en) |
HU (1) | HUP0104773A3 (en) |
IL (1) | IL143323A0 (en) |
NO (1) | NO20013001L (en) |
NZ (1) | NZ512765A (en) |
PL (1) | PL348815A1 (en) |
SK (1) | SK8192001A3 (en) |
WO (1) | WO2000035922A1 (en) |
ZA (1) | ZA200104598B (en) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6960579B1 (en) | 1998-05-19 | 2005-11-01 | Alcon Manufacturing, Ltd. | Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders |
US7012090B1 (en) | 2000-03-17 | 2006-03-14 | Alcon, Inc. | Pyranoindoles for treating glaucoma |
US6956036B1 (en) | 2000-03-17 | 2005-10-18 | Alcon, Inc. | 6-hydroxy-indazole derivatives for treating glaucoma |
US6806285B1 (en) | 2000-03-17 | 2004-10-19 | Alcon, Inc. | 5-Hydroxyl indole derivatives for treating glaucoma |
KR100539139B1 (en) | 2000-07-31 | 2005-12-26 | 에프. 호프만-라 로슈 아게 | Piperazine derivatives |
AR031196A1 (en) | 2000-11-03 | 2003-09-10 | Wyeth Corp | PROCEDURE FOR THE PREPARATION OF CYCLOPENTA (B) (1,4) -DIAZEPINO (6,7,1-HI) INDOLES AND DERIVATIVES |
US7141563B2 (en) | 2000-11-03 | 2006-11-28 | Wyeth | Process for the preparation of 1, 2, 3, 4, 8, 9, 10, 10a-octahydro-7bH-cyclopenta[b] [1, 4]diazepino[6, 7, 1-hi] indole derivatives |
AR031199A1 (en) | 2000-11-03 | 2003-09-10 | Wyeth Corp | CICLOHEPTA / B // 1,4 / DIACEPINO / 6,7,1-HI / INDOLES AND DERIVATIVES |
ES2230382T3 (en) * | 2000-11-03 | 2005-05-01 | Wyeth | CYCLOPENTAL (B) (1,4) DIAZPINO (6,7,1-HI) INDOLES AS 5HT2C ANTAGONISTS. |
AR031200A1 (en) | 2000-11-03 | 2003-09-10 | Wyeth Corp | CYCLOCATE [B] [1,4] DIAZEPINO [6,7,1-HI] INDOLES AND DERIVATIVES |
AR031202A1 (en) | 2000-11-03 | 2003-09-10 | Wyeth Corp | CYCLOPENTA (B) (1,4) DIAZEPINO (6,7,1-HI) INDOLES AND DERIVATIVES |
AR031195A1 (en) | 2000-11-03 | 2003-09-10 | Wyeth Corp | PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF 1,2,3,4,8,9,10,10A-OCTAHIDRO-7BH-CICLOPENTA (B) (1,4) DIAZEPINO (6,7,1) DIAZEPINO (6,7, 1-HI) INDOL |
SE0004245D0 (en) | 2000-11-20 | 2000-11-20 | Pharmacia Ab | Novel compounds and their use |
CA2449899C (en) | 2000-11-20 | 2010-04-06 | Biovitrum Ab | Piperazinylpyrazines compounds as antagonists of serotonin 5-ht2 receptor |
GB0030710D0 (en) | 2000-12-15 | 2001-01-31 | Hoffmann La Roche | Piperazine derivatives |
RU2003121406A (en) | 2000-12-20 | 2004-12-27 | Бристол-Маерс Сквибб Фарма Компани (Us) | DERIVATIVES OF SUBSTITUTED PYRASINOCHINOXALINS AS AN AGONISTS AND ANTAGONISTS OF THE SEROTONIN RECEPTOR |
AU2002228007B2 (en) * | 2000-12-27 | 2007-06-21 | F. Hoffmann-La Roche Ag | Indole derivatives and their use as 5-HT2b and 5-HT2c receptor ligands |
JPWO2002074746A1 (en) * | 2001-03-16 | 2004-07-08 | 山之内製薬株式会社 | Benzoazepine derivatives |
EP1392292B1 (en) | 2001-06-01 | 2006-03-01 | Alcon, Inc. | Pyranoindazoles and their use for the treatment of glaucoma |
WO2002098400A1 (en) | 2001-06-01 | 2002-12-12 | Alcon, Inc. | Novel arylaminopropane analogues and their use for the treatment of glaucoma |
EP1392658A4 (en) | 2001-06-01 | 2004-10-13 | Alcon Inc | Novel fused indazoles and indoles and their use for the treatment of glaucoma |
TW593302B (en) | 2001-12-20 | 2004-06-21 | Alcon Inc | Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma |
TW200307682A (en) | 2002-04-25 | 2003-12-16 | Wyeth Corp | 1,2,3,4,7,8-Hexahydro-6H-[1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents |
TW200307540A (en) | 2002-04-25 | 2003-12-16 | Wyeth Corp | [1, 4]Diazocino[7, 8, 1-hi] indole derivatives as antipsychotic and antiobesity agents |
TWI312781B (en) | 2002-04-25 | 2009-08-01 | [1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents | |
CA2485537A1 (en) | 2002-06-19 | 2003-12-31 | Biovitrum Ab | Novel compounds, their use and preparation |
WO2004054572A2 (en) | 2002-12-13 | 2004-07-01 | Alcon, Inc. | Novel benzopyran analogs and their use for the treatment of glaucoma |
AU2003303210A1 (en) | 2002-12-19 | 2004-07-14 | Bristol-Myers Squibb Company | Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists |
CL2004000826A1 (en) | 2003-04-25 | 2005-03-04 | Pfizer | USE OF AN AGONIST FOR THE 5-HT2C RECEPTOR TO PREPARE A USEFUL MEDICINAL PRODUCT IN THE TREATMENT OF URINARY INCONTINENCE CAUSED BY STRESS, WITH THE CONDITION THAT THE AGONIST IS NOT 1- [6-CHLORINE-5- (TRIFLUOROMETIL) -2- PIRIDINIL] PIPERAZINA (ORG-129 |
MXPA05013365A (en) * | 2003-06-20 | 2006-04-05 | Arena Pharm Inc | N-phenyl-piperazine derivatives and methods of prophylaxis or treatment of 5ht2c. |
GB0314967D0 (en) | 2003-06-26 | 2003-07-30 | Hoffmann La Roche | Piperazine derivatives |
WO2005053688A1 (en) | 2003-11-26 | 2005-06-16 | Alcon, Inc. | Substituted furo[2,3-g] indazoles for the treatment of glaucoma |
TW200520760A (en) | 2003-12-15 | 2005-07-01 | Alcon Inc | Substituted [1,4] oxazino [2,3-g] indazoles for the treatment of glaucoma |
US7129257B1 (en) | 2003-12-15 | 2006-10-31 | Alcon, Inc. | Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma |
US7338972B1 (en) | 2003-12-15 | 2008-03-04 | Alcon, Inc. | Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma |
EP2400300A1 (en) | 2004-08-25 | 2011-12-28 | Takeda Pharmaceutical Company Limited | Method of screening preventives/remedies for stress urinary incontinence |
WO2006037481A1 (en) * | 2004-09-30 | 2006-04-13 | F.Hoffmann-La Roche Ag | Benzoxazine and quinoxaline derivatives and uses |
GT200500317A (en) | 2004-11-05 | 2006-10-27 | PROCESS TO PREPARE QUINOLINE COMPOUNDS AND PRODUCTS OBTAINED FROM THEM | |
US7425572B2 (en) | 2004-12-08 | 2008-09-16 | Alcon, Inc. | Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma |
AR054849A1 (en) | 2005-07-26 | 2007-07-18 | Wyeth Corp | DIAZEPINOQUINOLINAS, SYNTHESIS OF THE SAME, AND INTERMEDIARIES TO OBTAIN THEM |
WO2007132841A1 (en) | 2006-05-16 | 2007-11-22 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compound and use thereof |
EP2216023A4 (en) | 2007-11-15 | 2013-03-13 | Takeda Pharmaceutical | Condensed pyridine derivative and use thereof |
KR101062376B1 (en) | 2008-04-10 | 2011-09-06 | 한국화학연구원 | Novel indole carboxylic acid bispyridyl carboxamide derivatives, preparation method thereof and composition containing the same as an active ingredient |
KR101110199B1 (en) | 2009-05-18 | 2012-03-14 | 한국화학연구원 | Piperazine-quinoline derivatives, pharmaceutically acceptable salts thereof, preparation method thereof and pharmaceutical composition for prevention or treatment of central nervous system diseases containing the same as an active ingredient |
US8575186B2 (en) | 2009-10-05 | 2013-11-05 | Albany Molecular Research, Inc. | Epiminocycloalkyl[b] indole derivatives as serotonin sub-type 6 (5-HT6) modulators and uses thereof |
US20120253036A1 (en) | 2009-12-11 | 2012-10-04 | Yukinori Nagakura | Agent for treating fibromyalgia |
CA2788416C (en) | 2010-02-04 | 2018-08-14 | The Board Of Trustees Of The University Of Illinois | Highly selective 5-ht(2c) receptor agonists having antagonist activity at the 5-ht(2b) receptor |
WO2012030953A1 (en) | 2010-09-01 | 2012-03-08 | Arena Pharmaceuticals, Inc. | 5-ht2c receptor agonists in the treatment of disorders ameliorated by reduction of norepinephrine level |
US9067949B2 (en) | 2011-01-19 | 2015-06-30 | Albany Molecular Research, Inc. | Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-HT6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia |
WO2015066344A1 (en) | 2013-11-01 | 2015-05-07 | Arena Pharmaceuticals, Inc. | 5-ht2c receptor agonists and compositions and methods of use |
CN107810175B (en) | 2015-01-29 | 2021-06-15 | 伊利诺伊大学评议会 | Cyclopropylmethylamines as selective 5-HT (2C) receptor agonists |
EP3733204A4 (en) | 2017-12-27 | 2021-09-15 | Takeda Pharmaceutical Company Limited | Therapeutic agent for stress urinary incontinence and fecal incontinence |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4032639A (en) * | 1976-03-22 | 1977-06-28 | American Home Products Corporation | 2,3,4,4A-Tetrahydro-1H-pyrazino[1,2-a,]quinoxalin-5(6H)-ones and derivatives thereof for relieving hypertension |
US4089958A (en) * | 1976-12-20 | 1978-05-16 | American Home Products Corporation | 2,3,4,4A-Tetrahydro-1H-pyrazino[1,2]quinoxalin-5(6)-ones and derivatives thereof |
US4203987A (en) * | 1979-05-21 | 1980-05-20 | American Home Products Corporation | 3-[Pyridinylalkyl and piperidinylalkyl]-2,3,4,4a-tetrahydro-1H-pyrazino[1,2-a]quinoxalin-5(6H)-ones |
GB8917333D0 (en) * | 1989-07-28 | 1989-09-13 | Merck Sharp & Dohme | Therapeutic agents |
EP0539209A1 (en) * | 1991-10-24 | 1993-04-28 | The Upjohn Company | Benzo-isoquinoline derivatives and analogs and their use in therapeutics |
AU4547796A (en) * | 1995-02-03 | 1996-08-21 | Sankyo Company Limited | Hexahydropyrazinoquinoline derivatives |
-
1999
- 1999-12-16 WO PCT/US1999/029894 patent/WO2000035922A1/en not_active Application Discontinuation
- 1999-12-16 AU AU31234/00A patent/AU3123400A/en not_active Abandoned
- 1999-12-16 PL PL99348815A patent/PL348815A1/en not_active Application Discontinuation
- 1999-12-16 KR KR1020017007583A patent/KR20010108025A/en not_active Application Discontinuation
- 1999-12-16 EP EP99965285A patent/EP1140940A1/en not_active Withdrawn
- 1999-12-16 IL IL14332399A patent/IL143323A0/en unknown
- 1999-12-16 AR ARP990106455A patent/AR022687A1/en not_active Application Discontinuation
- 1999-12-16 HU HU0104773A patent/HUP0104773A3/en unknown
- 1999-12-16 CA CA002351385A patent/CA2351385A1/en not_active Abandoned
- 1999-12-16 EA EA200100671A patent/EA200100671A1/en unknown
- 1999-12-16 CN CNB998144169A patent/CN1240701C/en not_active Expired - Fee Related
- 1999-12-16 SK SK819-2001A patent/SK8192001A3/en unknown
- 1999-12-16 JP JP2000588181A patent/JP2002532504A/en not_active Withdrawn
- 1999-12-16 BR BR9916326-8A patent/BR9916326A/en not_active IP Right Cessation
- 1999-12-16 CZ CZ20012193A patent/CZ20012193A3/en unknown
- 1999-12-16 NZ NZ512765A patent/NZ512765A/en unknown
-
2001
- 2001-06-05 ZA ZA200104598A patent/ZA200104598B/en unknown
- 2001-06-15 NO NO20013001A patent/NO20013001L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
HUP0104773A3 (en) | 2004-10-28 |
CN1240701C (en) | 2006-02-08 |
PL348815A1 (en) | 2002-06-17 |
AU3123400A (en) | 2000-07-03 |
JP2002532504A (en) | 2002-10-02 |
EA200100671A1 (en) | 2001-12-24 |
WO2000035922A1 (en) | 2000-06-22 |
SK8192001A3 (en) | 2001-12-03 |
ZA200104598B (en) | 2002-09-05 |
KR20010108025A (en) | 2001-12-07 |
IL143323A0 (en) | 2002-04-21 |
CZ20012193A3 (en) | 2001-12-12 |
CA2351385A1 (en) | 2000-06-22 |
NZ512765A (en) | 2003-10-31 |
NO20013001L (en) | 2001-06-15 |
EP1140940A1 (en) | 2001-10-10 |
CN1330652A (en) | 2002-01-09 |
AR022687A1 (en) | 2002-09-04 |
HUP0104773A2 (en) | 2002-04-29 |
BR9916326A (en) | 2001-10-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20013001D0 (en) | 2,3,4,4A-tetrahydro-1H-pyrazino (1,2-A) quinoxaline-5 (6H) one derivatives which are 5HT2C agonists | |
LU93311I2 (en) | MANCOZÈBE, VALIFENALATE | |
MA26520A1 (en) | 5H-THIAZOLO (3,2-A) PYRIMIDINE DERIVATIVES. | |
NO20015477D0 (en) | 4,5,6,7-tetrahydroindazole derivatives as anti-tumor agents | |
NO20006454L (en) | Pyrrolo (2,3-d) pyrimidine | |
NO20006453L (en) | Pyrrolo (2,3-d) pyrimidine | |
ATE284404T1 (en) | PYRAZOLO(4,3-D)PYRIMIDINE DERIVATIVES | |
DZ3168A1 (en) | Purine derivatives. | |
ATE261970T1 (en) | TRIAZOLO(4,5-D)PYRIMIDINE DERIVATIVES | |
ATE435861T1 (en) | 12,13-CYCLOPROPANE-EPOTHILONE DERIVATIVES | |
ATE251625T1 (en) | 8-PHENYL-6,9-DIHYDRO-(1,2,4)TRIAZOLO(3,4-I)PURI - 5-ONE DERIVATIVES | |
TR199800085A3 (en) | 8-Substituted-1,3,8-triaza-spiro (4,5) decan-4-one derivatives. | |
TR199801804A3 (en) | Slide rail trigger assembly. | |
DZ2569A1 (en) | Substituted 1,2,3,4-tetrahydronaphthalene derivatives. | |
DK0915819T3 (en) | Illudin analogs used as antitumor agent | |
TR199802520A3 (en) | 1,3,8-Triaza-spiro (4,5) decan -4-on derivatives. | |
ATE204279T1 (en) | DIAZA-SPIRO(3,5)NONANENE DERIVATIVES | |
ID28539A (en) | IMIDAZO (1,2A) AZINA SUBSTITUTED AS A COX-2 SELECTIVE HOLDER | |
NO20003825L (en) | 1,3,4 - oxadiazolone derivatives | |
BR9701675A (en) | New pyrimido (1,2-a) indoles | |
ATE234302T1 (en) | DI-OR TRIAZASPIRO(4,5)DECANDERIVATES | |
ES1039281Y (en) | MODULAR STRUCTURE FOR LIGHTING. | |
ES1041562Y (en) | PERFECTED LAMP HOLDER. | |
ES1036214Y (en) | Stroller-stroller-backpack, for dolls. | |
ES1041578Y (en) | PERFECTED LIGHTING. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |